SB-649,915

From Infogalactic: the planetary knowledge core
(Redirected from SB-649915)
Jump to: navigation, search
SB-649,915
SB-649,915 structure.png
Systematic (IUPAC) name
6-[(1-[3-(2-methylquinolin-5-yl)oxypropyl]piperidin-4-yl)methyl]-4H-1,4-benzoxazin-3-one
Clinical data
Legal status
  • Uncontrolled
Identifiers
CAS Number ? YesY
ATC code none
PubChem CID: 10225553
IUPHAR/BPS 76
ChemSpider 8471882 N
ChEMBL CHEMBL183460 N
Chemical data
Formula C26H29N3O3
Molecular mass 431.526 g/mol
  • O=C4COc1ccc(cc1N4)CC(CC5)CCN5CCOc(cccc2n3)c2ccc3C
  • InChI=1S/C26H29N3O3/c1-18-5-7-21-22(27-18)3-2-4-24(21)31-14-13-29-11-9-19(10-12-29)15-20-6-8-25-23(16-20)28-26(30)17-32-25/h2-8,16,19H,9-15,17H2,1H3,(H,28,30) N
  • Key:PJSUYRBCBFPCQW-UHFFFAOYSA-N N
 NYesY (what is this?)  (verify)

SB-649,915 is a serotonin reuptake inhibitor and 5-HT1A and 5-HT1B receptor antagonist which is being investigated for its antidepressant effects.[1] Relative to the selective serotonin reuptake inhibitors (SSRIs), SB-649,915 has a faster onset of action and may also have greater clinical efficacy as well.[1] This can be attributed to blockade of 5-HT1A and 5-HT1B autoreceptors which inhibit serotonin release.[1]

See also

References

  1. 1.0 1.1 1.2 Lua error in package.lua at line 80: module 'strict' not found.